Physician profile
Sung Won Lee
NPI 1144296492
$11,695.21
in general payments reported to CMS, 2019-2025
42 companies · $1,468 in 2025
The $1,468 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,519 · 2020: $2,059 · 2021: $1,908 · 2022: $1,395 · 2023: $1,271 · 2024: $1,076 · 2025: $1,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,814.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,068.81 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $1,352.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,091.54 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Scilex Pharmaceuticals INC. | $998.52 | 2019-2025 | Ztlido |
| Boehringer Ingelheim Pharmaceuticals, INC. | $969.33 | 2019-2025 | Jardiance, Synjardy |
| Radius Health, INC. | $513.40 | 2019-2025 | Tymlos |
| Merck Sharp & Dohme LLC | $469.32 | 2019-2022 | |
| Amarin Pharma, INC. | $437.44 | 2019-2022 | |
| Abbvie INC. | $434.33 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $423.64 | 2019-2021 | |
| Pfizer INC. | $407.80 | 2019-2025 | |
| Lilly USA, LLC | $391.26 | 2019-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $301.71 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $261.88 | 2019-2025 | Shingrix, Arexvy |
| Allergan, INC. | $135.57 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung Won Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.